XENE News and Press, Xenon Pharmaceuticals Inc.

2024-05-15 05:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-09 20:05:29 ET Xenon Pharmaceuticals Inc. (XENE) Q1 2024 Earnings Conference Call May 9, 2024, 4:30 PM ET Company Participants Chad Fugere - Vice President, Investor Relations Ian Mortimer - President and CEO Dr. Chris Kenney - Chief Medical Officer D...

2024-05-09 16:41:24 ET More on Xenon Pharma Xenon Pharmaceuticals Inc. (XENE) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Xenon Pharma Historical earnings data for Xenon Pharma Financial information for Xenon Pharma Read ...

Phase 3 epilepsy program continues to progress with anticipated completion of patient enrollment in X-TOLE2 in late 2024 to early 2025 Successful “end-of-Phase 2” interactions with FDA in MDD; Phase 3 program on track to initiate in the second half of the year Azet...

2024-05-08 17:35:06 ET More on Xenon Pharma Seeking Alpha’s Quant Rating on Xenon Pharma Historical earnings data for Xenon Pharma Financial information for Xenon Pharma Read the full article on Seeking Alpha For further details see: Xenon ...

VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the BofA Securities Health Care Conference 2024 taking place May 14-16, 2024 in Las Vegas, NV....

VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the 2024 RBC Capital Markets Global Healthcare Conference taking place May 14-15, 2024 in New ...

2024-05-05 11:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

VANCOUVER, British Columbia, May 02, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced it will report its first quarter 2024 financial and operating results after the close of U.S. financial markets on Thursday, Ma...

2024-04-23 09:30:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the quarter ended March 31, 2024, Baron Health Care Fund advanced 8.92% compared wi...